“We absolutely have to stop this disease - there is just no choice. As a nation, we have to end it now.”

- David Shenk, Author, "The Forgetting"
Our Mission

ACT-AD is a coalition of committed national organizations seeking to accelerate the development of potential cures and treatments to slow, halt or reverse the progression of Alzheimer’s disease through research.

About ACT-AD Advisory Board Coalition Members Membership Information

  Recent News & Updates
All Updates All Resources Press Room

ACT-AD Member Spotlight: BrightFocus Foundation
Update
Webinar: The Emerging Antimicrobial Protection Hypothesis of Alzheimer’s Disease
Resource
Webinar: If You Build It, Will They Come? Strategies for Alzheimer’s Disease Clinical Trial Recruitment
Resource
ACT-AD at the 11th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Update
ACT-AD Letter on FDA Early Alzheimer’s Disease Guidance
Update
Researchers Reverse Alzheimer’s Disease in Mouse Models
Update
Experimental Drug Could Be Viable Treatment for Alzheimer’s Disease
Update
Canola Oil May Play a Role in Worsening of Alzheimer’s Disease Symptoms
Update